October 25th 2024
In all, 51.9% of patients entered with or achieved complete disease clearance at least once during the 48-week study.
September 27th 2024
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Segmental form of mosaic neurofibromatosis 1
December 8th 2020A healthy 16-year-old girl presented with asymptomatic lesions she had at birth. Examination revealed a 15 cm well-demarcated light brown hyperpigmented background patch localized to the right inguinal skin-fold and, within it, café-au-lait macules and patches, greater than 1.5 cm, with diffuse freckling.
Bruise-like marks on a healthy teenage male’s back
October 9th 2020A 15-year-old male first noticed the marks on his back during a recent vertical growth spurt. On exam there are multiple horizontal violaceous linear striae on his back. He is otherwise healthy and denies any history of back injury or exposure to topical or systemic steroids. What's the diagnosis?
Bully bullae in a toddler spreads across the body
August 17th 2020You are asked to evaluate a healthy 19-month-old boy with a history of recurrent blisters on his arms and legs for over a year that have now spread to his face. The blisters scab over quickly, ulcerate, and heal with post-inflammatory pigmentary changes. What's the diagnosis?
Newborn’s rash involves eyes and nose
July 14th 2020A healthy 11-day-old male infant is brought to the pediatric clinic for evaluation of rash. The rash started with a 2-mm papule on the left medial epicanthal fold 4 days before the clinic visit. A day before coming to the clinic, the rash had spread to the upper left eyelid and the nasal bridge. What's the diagnosis?
FDA approves Taltz for kids with plaque psoriasis
April 6th 2020The US Food and Drug Administration has approved ixekizumab (Taltz, Eli Lilly) injection, 80 mg/mL, for use in pediatric patients to treat moderate-to-severe plaque psoriasis. The approval means that the drug is the first interleukin 17A (IL-17A) agent available for use in pediatric patients.
Eucrisa approved for AD use in infants aged 3 months and older
April 1st 2020The US Food and Drug Administration has given approval for a supplemental new drug application for Eucrisa (crisaborole) that allows the nonsteroidal topical ointment to be used for treating mild-to-moderate atopic dermatitis (AD) in children aged as young as 3 months.